CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH) [NA]
Summary
This clinical trial update reports termination of a study evaluating guanfacine for reversing opioid-induced hyperalgesia in individuals with Chronic Pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Chronic Pain | NA | Status: TERMINATED